Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer cell

Showing results (1061-1070 of 3,827) with videos related to

Pageof 383
Sort By:
Cancer Cell|May 3, 2003
Connecting estrogen receptor function, transcriptional repression, and E-cadherin expression in breast cancerEric R Fearon
Cancer Cell|May 3, 2003
Inactivation of E2F3 results in centrosome amplificationHarold I Saavedra, Baidehi Maiti, Cynthia Timmers, et al.
Cancer Cell|May 3, 2003
Hypoxia promotes invasive growth by transcriptional activation of the met protooncogeneSelma Pennacchietti, Paolo Michieli, Maria Galluzzo, et al.
Cancer Cell|May 3, 2003
2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIFNicola J Mabjeesh, Daniel Escuin, Theresa M LaVallee, et al.
Cancer Cell|February 1, 2003
Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genesSilvia Montaner, Akrit Sodhi, Alfredo Molinolo, et al.
Cancer Cell|February 1, 2003
The RAG-1/2 endonuclease causes genomic instability and controls CNS complications of lymphoblastic leukemia in p53/Prkdc-deficient miceRebecca A Gladdy, Michael D Taylor, Christine J Williams, et al.
Cancer Cell|June 5, 2003
FANCF methylation contributes to chemoselectivity in ovarian cancerOlufunmilayo I Olopade, Minjie Wei
Cancer Cell|June 5, 2003
Adoptive immunotherapy: engineering T cell responses as biologic weapons for tumor mass destructionWilliam Y Ho, Joseph N Blattman, Michelle L Dossett, et al.
Cancer Cell|June 5, 2003
A peptide trivalent arsenical inhibits tumor angiogenesis by perturbing mitochondrial function in angiogenic endothelial cellsAnthony S Don, Oliver Kisker, Pierre Dilda, et al.
Cancer Cell|April 5, 2003
Progress in immunoconjugate cancer therapeuticsGillian Payne
Pageof 383

Showing results (1061-1070 of 3,827) with videos related to

Sort By:
Pageof 383
Cancer Cell|May 3, 2003
Connecting estrogen receptor function, transcriptional repression, and E-cadherin expression in breast cancerEric R Fearon
Cancer Cell|May 3, 2003
Inactivation of E2F3 results in centrosome amplificationHarold I Saavedra, Baidehi Maiti, Cynthia Timmers, et al.
Cancer Cell|May 3, 2003
Hypoxia promotes invasive growth by transcriptional activation of the met protooncogeneSelma Pennacchietti, Paolo Michieli, Maria Galluzzo, et al.
Cancer Cell|May 3, 2003
2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIFNicola J Mabjeesh, Daniel Escuin, Theresa M LaVallee, et al.
Cancer Cell|February 1, 2003
Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genesSilvia Montaner, Akrit Sodhi, Alfredo Molinolo, et al.
Cancer Cell|February 1, 2003
The RAG-1/2 endonuclease causes genomic instability and controls CNS complications of lymphoblastic leukemia in p53/Prkdc-deficient miceRebecca A Gladdy, Michael D Taylor, Christine J Williams, et al.
Cancer Cell|June 5, 2003
FANCF methylation contributes to chemoselectivity in ovarian cancerOlufunmilayo I Olopade, Minjie Wei
Cancer Cell|June 5, 2003
Adoptive immunotherapy: engineering T cell responses as biologic weapons for tumor mass destructionWilliam Y Ho, Joseph N Blattman, Michelle L Dossett, et al.
Cancer Cell|June 5, 2003
A peptide trivalent arsenical inhibits tumor angiogenesis by perturbing mitochondrial function in angiogenic endothelial cellsAnthony S Don, Oliver Kisker, Pierre Dilda, et al.
Cancer Cell|April 5, 2003
Progress in immunoconjugate cancer therapeuticsGillian Payne
Pageof 383